The Food and Drug Administration granted 42 orthopedic-related 510(k) clearances in October.
The Latest
Two Texas-based pain physicians have been charged in a $12 million fraud scheme and accused of unlawfully distributing controlled substances, accoring to a statement from the U.S. Attorney's Office of the Northern District of Texas.
The last few years have been tough on spine device companies.
Orthopedic spine surgery is dominated by white males, and that won't change any time soon, according to a study published in the journal Spine.
It's easier for surgeons experienced with minimally invasive transforaminal lumbar interbody fusions to incorporate robotic technology into their practice than it is for early career attendings, according to a study published in the journal Spine.
The volume of cervical disc replacements grew steadily for nearly a decade, but have leveled off in the last few years, according to a study published in the journal Spine.
Off-label use of bone morphogenic protein for spinal fusions has been widespread for years and could expose surgeons to malpractice allegations. But how often do those allegations lead to plaintiff wins?
ZimVie in 2023 saw decreases in its revenue, but the company also saw milestones in its spine portfolio.
Medical device company Catalyst OrthoScience has added Amy Ables, PhD, as its chief strategy officer effective immediately.
2023 was a big year for medical office building acquisitions and trades, with several facilities housing orthopedic practices being traded and constructed.